Veletri (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the Veletri drug offered from Actelion Pharmaceuticals US, Inc.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
NON-PROPRIETARY NAME: | epoprostenol sodium |
SUBSTANCE NAME: | EPOPROSTENOL SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-04-22 |
END MARKETING DATE: | 0000-00-00 |
Veletri HUMAN PRESCRIPTION DRUG Details:
Item Description | Veletri from Actelion Pharmaceuticals US, Inc. |
LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1500000(ng/10mL) |
START MARKETING DATE: | 2010-04-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66215-401_c21fe239-6ac6-46a2-b97c-84d9ad1a5c98 |
PRODUCT NDC: | 66215-401 |
APPLICATION NUMBER: | NDA022260 |
Other EPOPROSTENOL SODIUM Pharmaceutical Manufacturers / Labelers: